Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
1.32
Nov 16 • 3:59 PM ET Dollar change-0.04 Percentage change(-2.94%)
Aftermarket Close
1.32
Aftermarket • 4:04 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
6.07M
Enterprise Value
5.67M
Income
-5.01M
Sales
4.34M
Book/sh
0.79
Cash/sh
0.59
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
50
IPO
Mar 17, 1980
P/E
-
Forward P/E
-
PEG
-
P/S
1.40
P/B
1.66
P/C
2.22
P/FCF
-
EV/EBITDA
-
EV/Sales
1.31
Quick Ratio
1.33
Current Ratio
1.91
Debt/Eq
0.64
LT Debt/Eq
0.44
Option/Short
No / Yes
EPS (ttm)
-1.64
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
31.53% 23.66%
Sales past 3/5Y
-5.87% -9.16%
EPS Y/Y TTM
-6.64%
Sales Y/Y TTM
-11.20%
EPS Q/Q
-46825.00%
Sales Q/Q
-8.33%
Insider Own
17.86%
Insider Trans
13.68%
Inst Own
3.03%
Inst Trans
21.69%
ROA
-67.12%
ROE
-113.80%
ROIC
-95.70%
Gross Margin
0.90%
Oper. Margin
-125.22%
Profit Margin
-115.49%
SMA20
-18.35%
SMA50
-32.79%
SMA200
-33.84%
Trades
Shs Outstand
4.60M
Shs Float
3.78M
52W High
2.93 -55.03%
52W Low
1.27 3.94%
Volatility
10.20% 7.36%
ATR (14)
0.12
RSI (14)
26.52
Beta
0.43
Rel Volume
0.12
Avg Volume
71.80K
Volume
8,523
Perf Week
-14.84%
Perf Month
-28.65%
Perf Quarter
-17.50%
Perf Half Y
-41.33%
Perf YTD
-47.62%
Perf Year
-45.23%
Perf 3Y
-81.67%
Perf 5Y
-96.50%
Perf 10Y
-92.07%
Prev Close
1.36
Price
1.32
Change %
-2.94%
Consensus
Strong Buy
Avg. Price Target
$6.25
Implied Upside
+373.5%
Analysts3incl. previous ratings
Rating Distribution3 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
May 05, 2026Initiated
CCitizens
Mkt Outperform$9+581.8%
Nov 10, 2020Initiated
CColliers Securities
Buy$13+884.8%
Jan 04, 2018Initiated
BB. Riley FBR, Inc.
Buy$7.50+468.2%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gary M. HuffDirectorAug 20 '26Buy1.6031,25050,00051,250Aug 27 05:27 PM
MOATAZEDI DAVIDDirectorAug 26 '26Buy1.6010,00016,00040,625Aug 27 05:26 PM
Chin EricDirectorAug 26 '26Buy1.606,25010,00038,750Aug 27 05:26 PM
BARBIERI ALLENExecutive Vice ChairmanAug 26 '26Buy1.6020,00032,00073,542Aug 27 05:24 PM
Irani Zackary S.Chief Executive OfficerAug 26 '26Buy1.6031,25050,000242,570Aug 27 05:23 PM
Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. It focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, North America, Asia, South America, and Middle East. The company was founded in September 1971 and is headquartered in Irvine, CA.
CEO & DirectorMr. Zackary S. Irani
Executive Vice-Chairman of the Board & Corporate SecretaryMr. Allen C. Barbieri
Principal Financial Officer & Principal Accounting OfficerMs. Xiaoxuan Qu
Director of Manufacturing & Technical OperationsMs. Lucy Liu Ph.D.
Chief Commercial OfficerMr. Scott Madel